Clinical Trial Update: Dampening the Reproductive Axis With Continuous Kisspeptin [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating continuous kisspeptin to dampen the reproductive axis in Polycystic Ovary Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Kisspeptin (Kisspeptin)

Snippet

Sponsor: Stephanie B. Seminara, MD | Conditions: Reproductive Disorder, PCOS | Phase 1 | Status: COMPLETED